
    
      -  Prospective open labeled observational study

        -  Subjects: About 15 patients with secondary pulmonary hypertension due to IPF or
           pulmonary fibrosis associated with collagen vascular diseases.

        -  Method: 3 month trial of inhaled iloprost. Check the safty and measure the pulmonary
           arterial pressure by right heart catheterization, exercise capacity by 6 minute walking
           test, echocardiography, and quality of life questionnaires before and after the trial.
    
  